View Older Stories View More Recent Stories

Mar 17, 2020 03:00AM 4D Pharma Presents Additional Interim Clinical Data From Combination Study for Lead Oncology Candidate
Mar 15, 2020 03:00PM Seres Therapeutics to Virtually Present at the Chardan Microbiome Medicines Summit
Mar 11, 2020 04:02PM Synlogic to Present at Chardan's Virtual Microbiome Medicines Summit
Mar 10, 2020 05:33PM LifeSci Acquisition Corp. Announces Closing of $60 Million Initial Public Offering
Mar 10, 2020 04:30PM Axial Biotherapeutics to Present at the Chardan 2nd Annual Microbiome Medicines Virtual Summit
Mar 10, 2020 11:44AM Krystal Biotech (KRYS) PT Raised to $100 at Chardan Capital Markets
Mar 10, 2020 08:30AM Kaleido Biosciences to Present During Chardan’s 2nd Annual Microbiome Medicines Summit
Mar 10, 2020 08:30AM Kaleido Biosciences to Present During Chardan’s 2nd Annual Microbiome Medicines Summit
Mar 9, 2020 04:30PM Passage Bio Announces Exercise of Underwriters’ Option to Purchase Additional Shares
Mar 9, 2020 04:30PM Passage Bio Announces Exercise of Underwriters’ Option to Purchase Additional Shares
Mar 9, 2020 06:02AM Form S-1 Chardan Healthcare Acqui
Mar 6, 2020 08:12AM Chardan Capital Markets Starts NeuBase Therapeutics (NBSE) at Buy
Mar 6, 2020 05:41AM LifeSci Acquisition Corp (LSAC) Prices 6M Unit IPO at $10/Unit
Mar 6, 2020 02:35AM Chardan Capital Markets Upgrades Arbutus Biopharma (ABUS) to Buy Ahead of HBV Clinical Data
Mar 5, 2020 09:28PM LifeSci Acquisition Corp. Announces Pricing of $60 Million Initial Public Offering
Mar 3, 2020 10:31AM uniQure BV (QURE) PT Lowered to $105 at Chardan Capital Markets
Mar 3, 2020 07:00AM uniQure to Participate in Multiple Upcoming Industry Conferences in March
Mar 2, 2020 04:05PM uniQure Announces 2019 Financial Results and Highlights Recent Company Progress
Feb 28, 2020 02:34PM Form X-17A-5 CHARDAN CAPITAL MARKETS For: Dec 31
Feb 28, 2020 12:02PM Passage Bio (PASG) IPO Opens 24% Higher
Feb 28, 2020 05:55AM Passage Bio, Inc. (PASG) Prices 12M Share IPO at $18/Sh
Feb 27, 2020 07:25PM Passage Bio Announces Pricing of Initial Public Offering
Feb 27, 2020 07:24PM Passage Bio Announces Pricing of Initial Public Offering
Feb 25, 2020 11:07AM Update: EdtechX Holdings (NASDAQ: EDTX) : Trading Update From Meten International Education Group
Feb 25, 2020 08:31AM EdtechX Holdings (NASDAQ: EDTX) : Trading Update From Meten International Education Group
Feb 25, 2020 06:12AM Trading Update Meten International Education Group
Feb 25, 2020 06:11AM Trading Update Meten International Education Group
Feb 24, 2020 04:01PM Axovant Gene Therapies Announces Closing of $74.7 Million Public Offering of Common Shares and Prefunded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Feb 24, 2020 06:13AM Chardan Capital Markets Starts Homology Medicines (FIXX) at Buy
Feb 20, 2020 05:53AM Axovant (AXGT) Prices 14.03M Share Common Offering at $3.75/Sh
Feb 19, 2020 10:11PM Axovant Gene Therapies Announces Pricing of $65 Million Public Offering
Feb 18, 2020 04:05PM Catalyst Biosciences Announces Closing of Public Offering of Common Stock
Feb 14, 2020 07:31AM Newborn Acquisition Corp. (NBAC) Prices 5M Unit IPO at $10/Unit
Feb 14, 2020 07:30AM Newborn Acquisition Corp. Announces Pricing of $50 Million Initial Public Offering
Feb 13, 2020 09:16AM Catalyst Biosciences (CBIO) Prices 4.6M Shares at $6.50
Feb 13, 2020 09:15AM Catalyst Biosciences Announces Pricing of Public Offering of Common Stock
Feb 12, 2020 05:56AM UPDATE: Moderna (MRNA) Prices 26.32M Share Common Offering at $19/Sh
Feb 11, 2020 10:12PM Moderna Announces Pricing of Public Offering of Shares of Common Stock
Feb 10, 2020 09:55AM UPDATE: Chardan Capital Markets Upgrades Adverum Biotechnologies (ADVM) to Buy
Feb 6, 2020 12:10PM Applied Genetic Technologies Corp. (AGTC) PT Raised to $10 at Chardan Capital Markets
Jan 31, 2020 10:52AM Esperion Therapeutics (ESPR) PT Raised to $65 at Chardan Capital Markets
Jan 30, 2020 10:44AM Buy Regenxbio (RGNX) for Breakup Story - Chardan Capital Markets
Jan 28, 2020 04:30PM BioPharmX And Timber Pharmaceuticals Announce Entry into Merger Agreement
Jan 27, 2020 05:22PM Chardan Capital Markets Reiterates Buy Rating on 4D Pharma Plc (DDDD:LN)
Jan 24, 2020 08:00AM SPAC Research Releases League Tables Featuring Top SPAC Underwriters and Law Firms of 2019
Jan 9, 2020 08:01AM Chardan Capital Markets Starts Immunovant (IMVT) at Buy; Named Top 2020 Pick
Dec 23, 2019 04:05PM Exicure Announces the Closing of its Offering of Common Stock
Dec 19, 2019 01:29PM Chardan Acts as M&A Advisor in Health Sciences Acquisitions Corporation Completed Merger with Immunovant
Dec 19, 2019 09:22AM Exicure Inc. (XCUR) Prices 10M Share Common Offering at $2.75/Sh
Dec 19, 2019 09:20AM Exicure Announces Pricing of $27.5 Million Public Offering of Common Stock
View More Recent Stories View Older Stories